These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 1020124)

  • 21. [Renal and intrarenal blood flow in essential arterial hypertension].
    Merkel C; Gatta A; Milani L; Amodio P; Lauro S; Zuin R
    Minerva Nefrol; 1980; 27(4):599-602. PubMed ID: 7254684
    [No Abstract]   [Full Text] [Related]  

  • 22. To the editor: limitations of 133 Xe washout technique in estimation of renal blood flow.
    Gutman RA
    Am J Physiol; 1973 Mar; 224(3):723. PubMed ID: 4691291
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in some hemodynamic indices in hypertensions].
    ISAZADE GM
    Azerbaidzhanskii Meditsinskii Zhurnal; 1962 Dec; 12():13-8. PubMed ID: 13956766
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical connotations of the experimental hypertensions.
    CORCORAN AC
    Can Med Assoc J; 1959 Aug; 81(3):145-54. PubMed ID: 13671393
    [No Abstract]   [Full Text] [Related]  

  • 25. A lot of primary arterial hypertensions. Only one blood pressure therapeutic target?
    Cinteza M
    Maedica (Bucur); 2014 Mar; 9(1):3-5. PubMed ID: 25553118
    [No Abstract]   [Full Text] [Related]  

  • 26. Low renal papillary plasma flow in both Dahl and Kyoto rats with spontaneous hypertension.
    Ganguli M; Tobian L; Dahl L
    Circ Res; 1976 Sep; 39(3):337-41. PubMed ID: 954162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of intrinsic natriuretic capacity in kidneys of Dahl hypertension-prone rats.
    Tobian L; Lange J; Azar S; Iwai J; Koop D; Coffee K
    Trans Assoc Am Physicians; 1977; 90():401-6. PubMed ID: 611669
    [No Abstract]   [Full Text] [Related]  

  • 28. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
    Tian N; Rose RA; Jordan S; Dwyer TM; Hughson MD; Manning RD
    J Hypertens; 2006 Nov; 24(11):2263-70. PubMed ID: 17053549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salt (NaCl) and hypertension: pathogenetic considerations.
    Tobian L
    Curr Concepts Nutr; 1981; 10():101-11. PubMed ID: 7249678
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduced renal papillary plasma flow in Dahl and Kyoto spontaneous hypertensions.
    Tobian L; Ganguli M; Dahl L
    Trans Assoc Am Physicians; 1976; 89():254-62. PubMed ID: 1020124
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopamine: vascular and renal effects and alterations in hypertension.
    Elghozi JL; Earnhardt JT; Meyer P
    Adv Nephrol Necker Hosp; 1984; 13():135-50. PubMed ID: 6433664
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.